10-Q: Syra Health Corp. Reports Increased Losses in Q3 2024 Amid Revenue Growth and Operational Expansion

Syra Health Corp. announced a net loss of $417,535 for the third quarter of 2024, an increase from the previous year's loss, despite a 42% rise in net revenues.

Summary

• Syra Health Corp. reported a net loss of $417,535 for the third quarter of 2024, compared to a net loss of $354,376 in the same period of 2023.
• Net revenues for Q3 2024 were $2,253,336, marking a 42% increase from $1,581,344 in Q3 2023.
• The company's cost of services rose by 54% to $1,585,038 in Q3 2024, up from $1,026,803 in the prior year's quarter.
• Operating expenses also increased to $1,097,208 in Q3 2024, compared to $897,557 in Q3 2023.
• For the nine months ended September 30, 2024, Syra Health reported a net loss of $3,254,841, an increase from a net loss of $1,943,068 in the same period of 2023.
• Nine-month revenues for 2024 were $5,975,357, up 59% from $3,748,943 in the corresponding period of 2023.
• The company completed a public offering on September 11, 2024, raising net proceeds of $1,619,021.

Sentiment

Score: 3

Explanation: The increased losses, going concern issues, and Nasdaq non-compliance notices contribute to a negative sentiment, despite some revenue growth.

Positives

• Revenue growth was driven by new customer acquisitions and additions to existing contracts.
• Population health and digital health services saw increased revenues due to additional services provided.
• The company successfully completed a public offering, raising additional capital.

Negatives

• Net loss increased in Q3 2024 compared to Q3 2023.
• Cost of services increased by 54% in Q3 2024.
• Gross profit margin decreased by 5% in Q3 2024.
• Operating expenses rose due to increased operations and regulatory filing costs.
• The company is not in compliance with Nasdaq's $1.00 minimum bid price requirement.

Risks

• The company may not have sufficient funds to sustain operations for the next twelve months.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company may need to raise additional capital, which may not be available on favorable terms.
• Failure to comply with Nasdaq's continued listing standards could result in delisting.
• Delisting could depress the stock price, limit liquidity, and adversely affect the ability to raise capital.
• The company's Executive Chairman is currently on a long-term medical leave.

Future Outlook

The company believes that existing sources of liquidity, along with cash expected to be generated from sales, will not be sufficient to fund operations, capital expenditures, working capital, and other financing requirements for at least the next twelve months.

Management Comments

• In an effort to reduce its operating costs, the Company, effective August 1, 2024, instituted a 25% payroll reduction for its executive officers.
• Our CEO, Deepika Vuppalanchi, has taken over Mr. Allams responsibilities while he is on medical leave.

Industry Context

The company operates in the healthcare services industry, focusing on preventative health, health education, and digital health solutions. The industry is experiencing growth, particularly in areas like population health and digital health, driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in technology.

Comparison to Industry Standards

• Compared to Teladoc Health, Inc. (TDOC), a leading telehealth company, Syra Health's revenue growth is significant, but Teladoc has a much larger revenue base ($660.2 million in Q3 2023) and positive net income.
• AMN Healthcare Services, Inc. (AMN), a major healthcare workforce solutions provider, reported Q3 2023 revenue of $848 million and net income of $35 million, significantly outperforming Syra Health in both revenue and profitability.
• Elevance Health, Inc. (ELV), a large health insurance provider, reported Q3 2023 revenue of $42.5 billion and net income of $1.6 billion, demonstrating a vastly different scale and financial performance compared to Syra Health.

Management Changes

Legal Proceedings

• In January 2024, a former employee filed a wrongful termination lawsuit against the Company in the U.S. District Court, Southern District of Indiana. The Company plans to vigorously defend itself against the claims, which it believes are without merit.

Related Party Transactions

• The company paid $101,411 for payroll and related costs for employees providing services to STLogics, an entity beneficially owned by the principal owners and management team of Syra.
• The company leases its corporate headquarters from STVentures, an entity beneficially owned by the principal owners and management team of Syra, for a base monthly rent of $11,209.
• The company incurred $16,233 of services from RAD CUBE LLC, an entity beneficially owned by the principal owners and management team of Syra, for outsourced IT services.
• The company paid $421,013 for recruitment and human resource services from NLogix, an entity beneficially owned by the principal owners and management team of Syra.

Stakeholder Impact

• Shareholders: Potential delisting from Nasdaq and ongoing losses could negatively impact shareholder value.
• Employees: The company's financial situation and potential need for cost reductions could impact job security.
• Customers: The company's ability to continue providing services could be affected if financial challenges are not addressed.
• Creditors: The going concern issue raises concerns about the company's ability to meet its financial obligations.

Next Steps

• The company will continue to monitor expenditures and cash flow position.
• Management will seek additional financing or attempt to conserve cash by further reducing expenses if sales do not materialize at the expected rates.
• The company needs to address the Nasdaq non-compliance issues to avoid delisting.

Key Dates

Keywords

healthcare services, preventative health, health education, population health, behavioral health, mental health, healthcare workforce, digital health, staffing solutions, health equity, patient-centric solutions, government agencies, integrated health networks, managed care, pharmaceutical manufacturers